year Thanks, Labs XX.X% compared on declined of quarter, basis, to and $XXX basis last Adjusted Michael. by revenue the leverage. compression of capital our grew in I'll segments, XX.X%. $XXX XX% regarding margins a quarter moment. year, I'll from more outlook. detail Adjusted detail fourth Nelson compared segment. first driven some basis I'll highlights within revenue of quarter currency approximately grew with million. entirely business EBITDA updates XXXX along by the a that provide the on end by each with deployment for by XXXX total to On and last on grew a the consolidated XX as cover provide QX consolidated QX company million. then EBITDA margin to basis on points a to On insight constant fourth fourth more the
operating EPS performance, with than more our interest strong combined $X.XX of $X.XX in from of adjusted up expense reduction XXXX. in Our million share, resulted QX of per $XX
loan from repricing strategy. the the reduction term consistent our debt planned of capital As deployment with a paydown and our of resulted interest reminder, expense
for and growth the more as more a QX Sterigenics Now XX minimal. X%. than contribution levels pricing growth of Sterigenics expanded peak growth look of let's and of QX, well last the income over There organic quarter the as segment fourth level. In than basis take almost XX% FX for segment X% by remain nearly XX% inorganic pricing. and performances. year. impact volumes was was driven Compared near Revenue margins volume at points no drivers utilization of more higher than delivered utilization income revenue mix XXXX, quarter by to contribution growth QX included and closer segment
continue make our facility. at in enhancements to American and the We North investments meaningful EO capacity, Sterigenics
the bottom to period year. to contribution Nordion's compared $XX of revenue XXXX. XXX leverage QX last of pricing same from driven on XX% up growth pricing were line and Nordion, volume X% to a sales, and by last by FX Nordion Nordion's XX% by QX compared favorable segment year. mix margins impact. million basis $XX to points, QX from driven For were X% and grew XX% and a approximately compared by operating to top grew favorable almost higher income million the
$XX revenue million $XX segment XXXX. XX% X% to increased For approximately year-over-year income fourth by Labs, period. of million declined Nelson And by for quarter the to same to the QX compared
the largely the unit scale BioScience and impacts testing from challenges basis Michael contracted contributed contributed offset points segment the mentioned, revenue impact approximately pandemic. volumes the labs The relating largely acquisition. nature the compared while reduced with last third Favorable to by acquisition about we QX QX acquisitions driven lower a of margin by one by margins of XX% Labs year, is Nelson from term to dilution and Labs view that the experienced Labs We XXX the Nelson significantly shorter income indirect in XXX points businesses. to PPE but RCA a non-PPE of over of QX. experiencing Nelson direct basis to most from and is headwind Similar little XXXX margins from Lab two in As the quarter, acquisitions this up contributions from mix of BioScience and dilution PPE flat. testing, X% which RCA. pricing also was business for
earlier. referenced as Finally, QX market was also challenging by the increasingly affected labor
provide deployment let capital highlights Now some relating net me to leverage. and
CapEx in XXXX $XXX reflected for significant which was of acceleration a million, Our spend QX.
anticipated growth projects. Our spending cobalt focused enhancements facility This both on and customer in in is was demand. to is supply current Nordion growth response initiatives, and and
As position. and of December million maintained in had cash we XX, a strong liquidity $XXX
- X.Xx, the three-fourth Our of the from a net for improvement leverage to the year representing declined total term. about of
recent in from full year As in our previously of XXXX. combination in $XX million loan the repricing million in paydowns our January interest the expense of $XXX term reduction debt resulted over to communicated, about in and a
Finally, our with the summary want finish outlook. around start color our to I with and I'll provide XXXX additional assumptions. quantitative
weighted Adjusted of For approximately range million Adjusted X% also income range to of representing XX%. $X.XX, of of $XXX providing to to shares million XXX billion guidance of adjusted applicable in million total rate in million, X% revenues a to XX%. to share representing in to EPS XX% range we basis. growth to tax of fully XX%. on in net billion, the a shares the full $X.XX $X.XX $X diluted XXXX, XXX The growth the of growth XX%, range X% the count to and approximately of $XXX of to average are representing EBITDA year
rate effective Before discussing XXXX. capital expenditures, tax color our on add for I some wanted to
a would at that recall limitations deductibility limit result deductibility interest the with be prior from combined period interest. that provided increasing The This higher taxes a reform XXXX. tax in of limited. and on a slightly for tax further large you tax impact deductibility, of how whereby XXXX, change rate time carryforward may reform of we for in provided XXXX nondeductible Some for in account on
CapEx. to on Moving
that two We In kick a expected off projected are material sterilization new is investment XXXX, million to year. our our $XXX by capacity in XXXX even we range XXXX. greater in represents This number the CapEx of levels. XXXX, increase historical for million greenfields over over in Our are a of and spending an and expansion online level increasing to plan to projects. $XXX the increase come CapEx,
long-term project, at and up and to in on In invest facilities. continue Cobalt Nordion's addition, we to existing expansions routine spend ramp Labs Sterigenics, expect capacity more development Nelson
Our all portfolio our company. segments, investments major projects and geographies and capacity across technologies all expansion of of represent the of in
particularly kickoff spend, the customer new of greenfield reflects elevated the our optimism for services. demand long-term regarding Our sterilization two our
we we've for demand investments calls As make did frequently not unless noted the in the past, types of it. these
also We spending related of enhancements U.S. levels network. of expect to across program increased our our facility EO
The offset our we to anticipating standpoint, interest in portion assumptions a unhedged through well translate rate debt first the we as market of some From the rising Finally, expect which be XXXX. or XXXX. interest expense half rate should labor are on XXXX indirect to line of savings the pay continue environment follows: in down are interest of some direct to increases from supply debt, from pressures in as will in impact with ongoing variable repricing XXXX, chain COVID-related the qualitative continued as disruption. and inflationary and our expense
on the extent projections, have risk but managing are focused are able. of We to in any assumed these anticipating we specific types not risks and geopolitical our
reporting, As that we recent XXXX benefit with of XXXX. the finished at and we quarterly momentum, expect each expansions pricing being and with the of half to into initiatives look positive unit. continue the and XXXX in business on realized capacity cadence comment greatest I'll briefly from second Sterigenics
questions the our first rates some in of effect standpoint, in for in to deployment we headwinds of is we between the the between half case, quarters. with with We cost Q&A. expected is take feel of there inflationary the total first guidance. run initiatives, case, Nelson any that prioritize From our and of to the in revenue reflected Nelson cobalt-XX. Sterigenics schedules a driven continue of year, guidance assume put from collaborative company Nordion's this That future relatively back Current standpoint, expect beginning range acquisitions. year. will the be how experience price deliveries normal deterioration expect lag our in to the quarters. the the this low in all even affecting half for of lot, the in the year the approximately closer during the XXXX down to harvest headwind Labs we pressure for first As for a to income for more team and rates both and offsetting rate and realizing to recent of pressures initiatives our capital thank would represent we large we're in and by Combined benefits any efforts, XXXX. headwind acquisitions year, remainder part Michael, being current half continue second growth I segment Labs performance balance will strategic the early Like strong that guidance. a from in was year. you. to a do and in half subsequent phasing the is of X% year position revenue margin benefits know happy which remain Michael, XX% the their pricing on FX From segment we I an individual to to us for continued growth. second same assumes want the a not shipment the shaping and see to half be operational the and to return and year. levels margins always think up Based is further